PI4Kβ/PKG-IN-2
PI4Kβ/PKG-IN-2 (Compound 20) is an orally active dual inhibitor of Plasmodium phosphatidylinositol 4-kinase beta (PI4Kβ) and cGMP-dependent protein kinase (PKG) . PI4Kβ/PKG-IN-2 has potent inhibitory effects on Plasmodium. PI4Kβ/PKG-IN-2 is promising for research of malaria[1].
Product Specifications
CAS Number
[3099010-20-2]
UNSPSC
12352005
Target
Parasite; PI4K; PKG
Related Pathways
Anti-infection; PI3K/Akt/mTOR; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
NC1=NC2=CC(C3=NN(CC4=CC=C(Cl)C(Cl)=C4)C5=NC=NC(N)=C53)=CC=C2O1
Molecular Formula
C19H13Cl2N7O
Molecular Weight
426.26
References & Citations
[1]Gachuhi S, et al. Medicinal Chemistry Progression of Sapanisertib, the Anticancer and Dual Plasmodium Phosphatidylinositol 4-Kinase Beta and cGMP-Dependent Protein Kinase Inhibitor, for Malaria. J Med Chem. 2025 Jun 12;68 (11) :10757-10770.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1395500-01 0.02 mg (E-Coli)
Recombinant Streptococcus agalactiae serotype III Glycine--tRNA ligase alpha subunit (glyQ)
Ask
View Details 
MBS1395500-02 0.02 mg (Yeast)
Recombinant Streptococcus agalactiae serotype III Glycine--tRNA ligase alpha subunit (glyQ)
Ask
View Details